{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-017239","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2025-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.170712+00:00","generated_at":"2026-05-21T04:44:15.928441+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"DiaMedica shareholders elect all 7 director nominees, ratify auditor, approve say-on-pay","bullets":["Michael Giuffre, Rick Kuntz, Tanya Lewis, Daniel O'Connor, James Parsons, Rick Pauls, Charles Semba elected with 96.3% or more of votes cast.","Appointment of Baker Tilly US, LLP as auditor for FY2025 approved with 95.5% of votes cast.","Advisory vote on executive compensation passed with 94.1% of votes cast (excluding broker non-votes).","Quorum reached with 45.1% of outstanding shares (19.34M of 42.86M) present at May 15, 2025 AGM."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-017239","json":"https://secwatch.observer/filing/0001437749-25-017239.json","markdown":"https://secwatch.observer/filing/0001437749-25-017239.md","text":"https://secwatch.observer/filing/0001437749-25-017239.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925017239/0001437749-25-017239-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925017239/dmtp20250515_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T04:44:15.928441+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}